Pulmonx Corporation Board of Directors

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Mr. Steven S. Williamson

Mr. Steven S. Williamson

CEO, President & Director

Mr. David A. Lehman J.D.

Mr. David A. Lehman J.D.

General Counsel & Secretary

Mr. Geoffrey Beran Rose

Mr. Geoffrey Beran Rose

Chief Commercial Officer

Mr. Mehul Joshi

Mr. Mehul Joshi

Chief Financial Officer

Ms. Lisa Paul

Ms. Lisa Paul

Chief People Officer

Ms. Lauren Cristina

Ms. Lauren Cristina

Vice President of Finance & Administration (U.S.)

Mr. Jérôme Erath

Mr. Jérôme Erath

Senior VP & GM of Europe Middle-East & Africa

Ms. Marcee M. Maroney

Ms. Marcee M. Maroney

Vice President of Marketing

Mr. Sri Radhakrishnan

Mr. Sri Radhakrishnan

Chief Technical Officer

Sarah Huber

Sarah Huber

Vice President of Sales (U.S.)

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.